Low-dose hCG is added to IVF stimulation protocols to help larger follicles mature more effectively, potentially improving embryo quality while using less of the primary stimulation hormone (FSH). It works by mimicking the body’s natural luteinizing hormone (LH), which plays a critical role in the final stages of follicle development. Doses typically range from 50 to 200 IU per day, far smaller than the thousands of units used for the final “trigger shot” before egg retrieval.
How Low-Dose hCG Works During Stimulation
During a natural menstrual cycle, FSH drives early follicle growth, and then LH takes on a larger role as follicles reach a certain size. The cells surrounding the egg develop LH receptors as they mature, making them responsive to LH signaling. hCG binds to those same receptors, so adding a small daily dose during IVF stimulation essentially fills in for LH at the point when growing follicles need it most.
This matters because many IVF protocols deliberately suppress your body’s own LH production. GnRH antagonist and agonist protocols block the brain’s signals that would normally trigger an LH surge, preventing premature ovulation. That suppression is necessary, but it also means the maturing follicles lose access to LH activity at a stage when they naturally rely on it. Low-dose hCG restores some of that activity in a controlled way.
Because only larger, more developed follicles have acquired LH receptors, the low-dose hCG selectively supports those follicles without stimulating the smaller ones. This can reduce the total number of small developing follicles while still promoting the maturation of the ones most likely to produce viable eggs.
Typical Dosing and Timing
Most protocols use between 50 and 200 IU of hCG per day, added alongside or partially replacing FSH during the stimulation phase. Research has suggested that 100 to 150 IU per day is the sweet spot: one study found that supplementation with hCG from the first day of stimulation at these doses increased the number of top-quality embryos per patient and was compatible with high live birth rates.
Some clinics start the hCG on cycle day 1 of stimulation, while others introduce it in the mid-follicular phase, once the lead follicles have grown large enough to respond. The timing depends on the overall protocol. In some cases, 200 IU per day has been used for the first five days of stimulation in patients who had previously failed IVF attempts. Your clinic will tailor the dose and start date based on your specific protocol type and response history.
Reducing the Need for FSH
One practical benefit of adding low-dose hCG is that it can partially replace FSH in the later days of stimulation. Since hCG supports the larger follicles directly, clinics can sometimes lower the FSH dose once those follicles are responding. This has the potential to reduce medication costs and overall hormonal load without sacrificing the number of mature eggs retrieved.
The approach has been studied in both GnRH antagonist protocols and long GnRH agonist protocols, with daily hCG doses of 100 IU added to gonadotropin stimulation in each. In both settings, the hCG supplementation appeared to complement FSH rather than interfere with it.
Who Benefits Most
Low-dose hCG has been explored in several patient groups, though it’s not limited to any single profile.
- Poor responders: Women who produce few follicles with standard stimulation may benefit from adding low-dose hCG in the mid-follicular phase. The idea is to maximize the maturation of whatever follicles do develop, improving the chances of getting usable embryos from a limited response.
- Patients at risk for ovarian hyperstimulation syndrome (OHSS): Because low-dose hCG selectively supports larger follicles and reduces the growth of smaller ones, it has been studied as a strategy to lower OHSS risk. Fewer small follicles means less overall ovarian activity, which is the root cause of hyperstimulation.
- Women with suppressed LH levels: Some patients on aggressive suppression protocols end up with LH levels too low for optimal follicle maturation. Low-dose hCG fills that gap. This is particularly relevant for women with a condition called hypogonadotropic hypogonadism, where the body produces very little LH on its own.
Low-Dose hCG vs. the Trigger Shot
It’s important not to confuse daily low-dose hCG during stimulation with the hCG “trigger shot” given at the end of stimulation to induce final egg maturation before retrieval. The trigger shot uses much higher doses, typically 5,000 to 10,000 IU in a single injection. Low-dose daily hCG during stimulation uses roughly 100 IU per day, about 1 to 2 percent of a standard trigger dose.
Interestingly, the concept of dose reduction applies to the trigger shot as well. A study comparing 5,000 IU versus 10,000 IU trigger doses in high-risk patients (those with estrogen levels above 4,000 pg/mL) found that the lower trigger dose cut OHSS rates dramatically: 5.8% developed OHSS in the 5,000 IU group compared to 20.6% in the 10,000 IU group. That’s a completely different application than daily low-dose supplementation, but it reflects the same principle that less hCG, carefully dosed, can achieve good outcomes with fewer complications.
Impact on Embryo Quality
The most consistent finding across studies is that low-dose hCG supplementation tends to improve embryo quality rather than simply increasing the number of eggs retrieved. One research group reported that adding hCG from stimulation day 1 increased the number of top-quality embryos per patient. The mechanism likely relates to the more complete follicular maturation that LH-receptor stimulation provides: eggs from fully mature follicles tend to fertilize better and develop into healthier embryos.
Not all findings are uniformly positive, though. At least one study found that starting low-dose hCG on cycle day 1 in antagonist protocols was associated with delays in embryo development and reduced fertilization rates. This suggests that timing and protocol context matter. Starting too early, before follicles have developed enough LH receptors to respond, may not help and could potentially interfere with the process.
What This Means for Your Cycle
If your fertility specialist recommends adding low-dose hCG to your stimulation protocol, it will typically mean one additional small injection per day, or the hCG may be included in a combined medication. You won’t feel any difference from the injection itself. The goal is to fine-tune your follicular response behind the scenes.
The decision to use low-dose hCG depends on your protocol type, how your ovaries have responded in previous cycles, and your risk profile for OHSS. It’s not a standard part of every IVF cycle, but it’s a well-studied tool that clinics use to optimize stimulation for specific situations. If you’ve had a poor response in a prior cycle or your doctor is adjusting your protocol to manage OHSS risk, low-dose hCG is one of the strategies they may reach for.